newsfilter
← Latest News
Business Wire·

Innate Pharma to Participate in the Kempen Life Sciences Conference

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its